Category Archives: Solutions

Enhancing Trauma-Informed Approaches in Behavioral Healthcare

https://newsletter.samhsa.gov/2017/08/11/trauma-at-root-of-mental-substance-use-disorder/

Teacher reading with children

Behavioral health service providers increasingly view trauma as an important element that must be addressed in providing effective services for mental and substance use disorders. Trauma may occur as a result of violence, abuse, neglect, loss, disaster, war and other emotionally harmful experiences. Left unaddressed, it may lead to long lasting effects that can compromise a person’s behavioral, emotional, cognitive, and physical health.

SAMHSA, through its Strategic Initiative on Trauma and Justice, has been a leader in identifying and supporting ways that service systems can become more attuned to trauma-related issues and skilled in responding to them.  Efforts include public education to raise awareness, prevention and early identification efforts, technical assistance for developing trauma-informed service environments, and trauma-specific treatment.

SAMHSA’s work in this area was strongly influenced by two seminal research studies:

Two of SAMHSA’s key efforts to address trauma are the National Child Traumatic Stress Network and the National Center for Trauma-Informed Care.

National Child Traumatic Stress Network

The National Child Traumatic Stress Network (NCTSN) is a nationwide network of researchers, intervention developers and service providers whose objective is to improve the access to and quality of services for children and families exposed to trauma. The NCTSN was established by Congress in 2000 under the Children’s Health Act that provides funding through the National Child Traumatic Stress Initiative (NCTSI). The NCTSI also supports a National Child Trauma Coordinating Center to manage the network, grants to intervention developers and grants for community service providers, as well as learning collaboratives in trauma-specific areas.

How NCTSN Works

As the network grantees and members work to address the needs of children and families, they also benefit from collaboration with one another. Treatment and Service Adaptation (TSA), centers run by universities and medical centers, develop evidence-based practices for which they then provide training throughout the network. Community Treatment and Services Centers of frontline and community organizations work together and also benefit from the TSA training.

The NCTSN facilitates the formation of collaborative workgroups or committees guided by strategic plans for specific areas such as child welfare, sexual abuse, trafficking, medical trauma, community trauma, and traumatic experiences of refugees and immigrants. These workgroups give grantees and members the opportunity to work together to advance practices with a specific topic in mind.

The NCTSN also hosts a Learning Center that offers free, open-forum training for providers and others supporting children who have experienced traumatic events. The trainings are self-paced and flexible, and CEUs are available for providers. This resource also includes podcasts, content on specific populations, and clinical training. Through the Learning Center and additional training events delivered by grantees, the NCTSN provides training to more than 200,000 participants annually.

National Center for Trauma-Informed Care and Alternatives to Seclusion and Restraint

SAMHSA’s National Center for Trauma-Informed Care and Alternatives to Seclusion and Restraint (NCTIC) focuses on reducing the use of seclusion and restraint through trauma-informed culture change in publicly funded organizations, systems, and communities. It provides training, technical assistance, and consultation to increase understanding and responsiveness to trauma in behavioral health, offering on-site and virtual support, as well as Virtual Learning Communities, webinars, and online tools.

NCTIC stresses the importance of involving trauma survivors and service recipients in all aspects of its work and in trauma-informed culture change, from conceptualization to implementation and evaluation.

In addition to providing technical assistance, facilitating collaboration, and awarding grants to continue this work, SAMHSA recently initiated an effort to train all agency staff in ways to understand and integrate a trauma-informed approach in SAMHSA grants, contracts, and program and policy development.

 

 Resources

On SAMHSA’s YouTube Channel

SAMHSA Blog

The post Enhancing Trauma-Informed Approaches in Behavioral Healthcare appeared first on .

Continue reading

Posted in Solutions | Comments Off on Enhancing Trauma-Informed Approaches in Behavioral Healthcare

September 20, 2017: Registered Nurse Sentenced for Tampering with Fentanyl

https://www.fda.gov/ICECI/CriminalInvestigations/ucm576936.htm

September 20, 2017: Registered Nurse Sentenced for Tampering with Fentanyl

Continue reading

Posted in Solutions | Comments Off on September 20, 2017: Registered Nurse Sentenced for Tampering with Fentanyl

Equifax or Equiphish?

More than a week after it said most people would be eligible to enroll in a free year of its TrustedID identity theft monitoring service, big three consumer credit bureau Equifax has begun sending out email notifications to people who were able to … Continue reading

Posted in credit lock, credit monitoring, Equifax, equiphish, Experian, Other, Solutions, Trans Union, trustedid.com, trustedidpremier.com | Leave a comment

Pharmaceutical Company Paying Penalty for Misleading Investors About Sales Metric

https://www.sec.gov/news/press-release/2017-175

The Securities and Exchange Commission today filed fraud charges against a Massachusetts-based biopharmaceutical company that exaggerated how many new patients actually filled prescriptions for an expensive drug that was its sole source of revenue.

Aegerion Pharmaceuticals, now a subsidiary of Novelion Therapeutics, has agreed to pay a $4.1 million penalty to settle the charges that it misled investors on multiple occasions in 2013.  The SEC’s complaint alleges that Aegerion told investors that the number of unfilled prescriptions for Juxtapid was not material and the “vast majority” of patients receiving prescriptions ultimately purchased the drug.  The SEC alleges that Aegerion’s records reflect that it was actually around 50 percent of prescriptions that resulted in actual drug purchases.

“By no one’s math is 50 percent a vast majority,” said Paul Levenson, Director of the SEC’s Boston Regional Office.  “When companies publicly discuss their financial data, they must be truthful.  Whether they supply hard numbers or give broader descriptions, they cannot mislead investors.”

According to the SEC’s complaint, Juxtapid is used to treat a rare and potentially life-threatening genetic condition that causes extremely high cholesterol.  In 2013 and 2014, it was priced at approximately $250,000 to $300,000 annually per patient.  Following Juxtapid’s introduction in 2013, investors and investment analysts had little financial data to estimate Aegerion’s future revenues from sales of the drug. 

Aegerion allegedly provided details on the number of Juxtapid prescriptions during several subsequent earnings calls, but this data alone was insufficient for analysts and investors trying to forecast the company’s future revenues because only prescriptions that were actually filled “converted” into sales. According to the SEC’s complaint, it wasn’t until October 2014 that Aegerion disclosed to investors that the conversion rate was actually in the range of 50 to 60 percent.  But Aegerion allegedly failed to reveal to investors even then that the conversion rate had hovered around 50 percent since 2013.

The SEC’s complaint, filed in federal court in Boston, charges Aegerion with violating Sections 17(a)(2) and (3) of the Securities Act of 1933.  Aegerion agreed to the settlement without admitting or denying the allegations.  The settlement is subject to court approval.

The SEC’s investigation, which is continuing, is being conducted by Emily R. Holness, Dawn A. Edick, Ruth Anne Heselbarth, Rachel Hershfang, Marc Jones, and Amy Gwiazda of the Boston office.  The SEC appreciates the assistance of the Federal Bureau of Investigation.

Continue reading

Posted in Solutions | Comments Off on Pharmaceutical Company Paying Penalty for Misleading Investors About Sales Metric

September 20, 2017: Registered Nurse Sentenced for Tampering with Fentanyl

September 20, 2017: Registered Nurse Sentenced for Tampering with Fentanyl

Posted in Solutions | Leave a comment

Experian Site Can Give Anyone Your Credit Freeze PIN

An alert reader recently pointed my attention to a free online service offered by big-three credit bureau Experian that allows anyone to request the personal identification number (PIN) needed to unlock a consumer credit file that was previously frozen at Experian. … Continue reading

Posted in credit freeze, Equifax, Experian, Other, Solutions | Leave a comment

Equifax Breach: Setting the Record Straight

Bloomberg published a story this week citing three unnamed sources who told the publication that Equifax experienced a breach earlier this year which predated the intrusion that the big-three credit bureau announced on Sept. 7. To be clear, this earlier breach at Equifax … Continue reading

Posted in credit lock, Elizabeth Warren, Equifax breach, Experian, Other, Solutions, TransUnion, TrueIdentity | Leave a comment

September 20, 2017: Miami-Dade Resident Sentenced to More Than 4 Years in Prison for Managing a Miami Spa Performing Illicit Silicone Injections

September 20, 2017: Miami-Dade Resident Sentenced to More Than 4 Years in Prison for Managing a Miami Spa Performing Illicit Silicone Injections

Posted in Solutions | Leave a comment

Investor Bulletin: Financial Professionals’ Use of Professional Honors – Awards, Rankings, and Designations

https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_professionalhonors

The SEC’s Office of Investor Education and Advocacy is issuing this Investor Bulletin to educate individual investors about the professional awards, rankings, and designations that financial professionals often use to market themselves to prospective clients.

Continue reading

Posted in Solutions | Comments Off on Investor Bulletin: Financial Professionals’ Use of Professional Honors – Awards, Rankings, and Designations

September 8, 2017: Galena Biopharma Inc. to Pay More than $7.55 Million to Resolve Alleged False Claims Related to Opioid Drug

September 8, 2017: Galena Biopharma Inc. to Pay More than $7.55 Million to Resolve Alleged False Claims Related to Opioid Drug

Posted in Solutions | Leave a comment